Currently, there are 2.78B common shares owned by the public and among those 2.77B shares have been available to trade.
The company’s stock has a 5-day price change of -1.12% and 27.12% over the past three months. JPM shares are trading 38.93% year to date (YTD), with the 12-month market performance up to 20.44% higher. It has a 12-month low price of $190.90 and touched a high of $296.40 over the same period. JPM has an average intraday trading volume of 8.73 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 1.96%, 6.86%, and 16.23% respectively.
Institutional ownership of JPMorgan Chase & Co (NYSE: JPM) shares accounts for 73.84% of the company’s 2.78B shares outstanding.
It has a market capitalization of $802.32B and a beta (3y monthly) value of 1.11. The stock’s trailing 12-month PE ratio is 14.17, while the earnings-per-share (ttm) stands at $20.37. The company has a PEG of 2.50 and the debt-to-equity ratio at 2.96. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.93% over the week and 1.67% over the month.
Analysts forecast that JPMorgan Chase & Co (JPM) will achieve an EPS of 4.47 for the current quarter, 4.48 for the next quarter and 19.63 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 4.1 while analysts give the company a high EPS estimate of 4.1. Comparatively, EPS for the current quarter was 6.12 a year ago. Earnings per share for the fiscal year are expected to increase by 2.62%, and 6.44% over the next financial year. EPS should shrink at an annualized rate of 5.66% over the next five years, compared to 12.99% over the past 5-year period.
Looking at the support for the JPM, a number of firms have released research notes about the stock. Keefe Bruyette stated their Outperform rating for the stock in a research note on July 09, 2025, with the firm’s price target at $327. HSBC Securities coverage for the JPMorgan Chase & Co (JPM) stock in a research note released on July 08, 2025 offered a Reduce rating with a price target of $259. Robert W. Baird was of a view on June 27, 2025 that the stock is Underperform, while TD Cowen gave the stock Buy rating on May 15, 2025, issuing a price target of $305. Robert W. Baird on their part issued Neutral rating on March 07, 2025.
